Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Next-Generation Influenza Vaccines
Masaru Kanekiyo, Barney S. Graham
Cold Spring Harbor Perspectives in Medicine (2020) Vol. 11, Iss. 8, pp. a038448-a038448
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Alexandra C. Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell (2020) Vol. 183, Iss. 5, pp. 1367-1382.e17
Open Access | Times Cited: 497
Quadrivalent influenza nanoparticle vaccines induce broad protection
Seyhan Boyoglu-Barnum, Daniel Ellis, Rebecca A. Gillespie, et al.
Nature (2021) Vol. 592, Iss. 7855, pp. 623-628
Open Access | Times Cited: 243
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial
Katherine V. Houser, Grace Chen, Cristina Carter, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 383-391
Open Access | Times Cited: 109
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans
Sarah F. Andrews, Lauren Y. Cominsky, Geoffrey D. Shimberg, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 692
Closed Access | Times Cited: 43
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults
Alicia T. Widge, Amelia R. Hofstetter, Katherine V. Houser, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 692
Open Access | Times Cited: 41
Next-generation vaccines for influenza B virus: advancements and challenges
M. Ashraf, Muhammad Asif Raza, Azka Imran, et al.
Archives of Virology (2025) Vol. 170, Iss. 2
Closed Access | Times Cited: 1
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidase
Julia Lederhofer, Yaroslav Tsybovsky, Lam Nguyen, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 574-586.e7
Open Access | Times Cited: 9
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future
Kristine A. Moore, Julie Ostrowsky, Alison M. Kraigsley, et al.
Vaccine (2021) Vol. 39, Iss. 45, pp. 6573-6584
Open Access | Times Cited: 52
The Coronavirus pandemic – 2022: Viruses, variants & vaccines
Magdalini Alexandridi, Julija Mazej, Enrico Palermo, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 63, pp. 1-9
Open Access | Times Cited: 35
Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses
Syed M. Moin, Jeffrey C. Boyington, Seyhan Boyoglu-Barnum, et al.
Immunity (2022) Vol. 55, Iss. 12, pp. 2405-2418.e7
Open Access | Times Cited: 29
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
Eduard Puente‐Massaguer, Kirill Vasilev, A. Beyer, et al.
Science Advances (2023) Vol. 9, Iss. 37
Open Access | Times Cited: 17
Computationally designed stem-epitope mimetics elicit broadly reactive antibodies
Sarah Wehrle, Andreas Scheck, Laura Reusch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The applications of live attenuated influenza A virus with modified NS1 gene
Hongbo Zhang, Lei Wang, Youcai An, et al.
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102471-102471
Open Access
Evaluation of a nanoparticle influenza vaccine in the pig model
Pauline M. van Diemen, Fabian Z. X. Lean, Andrew Ramsay, et al.
Vaccine (2025) Vol. 49, pp. 126844-126844
Closed Access
Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines
Seyhan Boyoglu-Barnum, Daniel Ellis, Rebecca A. Gillespie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 35
Evolving spike-proteinN-glycosylation in SARS-CoV-2 variants
Sabyasachi Baboo, Jolene K. Diedrich, Jonathan L. Torres, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 11
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Alexandra C. Walls, Brooke Fiala, Alexandra Schäfer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 27
Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer
Johnathan D. Guest, Ruixue Wang, Khadija Elkholy, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 3
Open Access | Times Cited: 22
Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines
Maya Sangesland, Daniel Lingwood
Vaccines (2021) Vol. 9, Iss. 2, pp. 125-125
Open Access | Times Cited: 21
Design and Preclinical Evaluation of a Nanoparticle Vaccine against Respiratory Syncytial Virus Based on the Attachment Protein G
Richard Voorzaat, Freek Cox, Daan van Overveld, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 294-294
Open Access | Times Cited: 2
Downstream processing for influenza vaccines and candidates: An update
Sofia B. Carvalho, Cristina Peixoto, Manuel J.T. Carrondo, et al.
Biotechnology and Bioengineering (2021) Vol. 118, Iss. 8, pp. 2845-2869
Closed Access | Times Cited: 16
Humoral Response to the Acetalated Dextran M2e Vaccine is Enhanced by Antigen Surface Conjugation
Cole J. Batty, Erik S. Pena, Eva A. Amouzougan, et al.
Bioconjugate Chemistry (2023) Vol. 34, Iss. 8, pp. 1447-1458
Open Access | Times Cited: 6
Materials‐based vaccines for infectious diseases
Bo Yang, Hua Wang
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 14, Iss. 5
Open Access | Times Cited: 9
Health impact and cost-effectiveness of vaccination using potential next-generation influenza vaccines in Thailand: a modelling study
Simon R. Procter, Naomi R. Waterlow, Sreejith Radhakrishnan, et al.
BMJ Global Health (2024) Vol. 9, Iss. 11, pp. e015837-e015837
Open Access | Times Cited: 1
Potentiating Lung Mucosal Immunity Through Intranasal Vaccination
Sean A. Nelson, Andrea J. Sant
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top